Popular weight-loss drugs have boosted Novo Nordisk and Eli Lilly. After huge gains, the drugmakers' stocks now face this risk.
Berkshire Hathaway, Eli Lilly, PepsiCo, Hovnanian and IDT are part of the Zacks top Analyst Blog.
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.